Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 36Terminated 8Unknown 6Withdrawn 4Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 6CNS 2Other solid neoplasm 1Other hematologic neoplasm 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Glioblastoma 1Brain Neoplasms 1

Interventions

Temozolomide 79Magnetic Resonance Spectroscopy 68Specimen Handling 45Radiotherapy 42Bevacizumab 29Radiosurgery 27Cyclophosphamide 27Radiation 20pembrolizumab 19Blood Specimen Collection 19fludarabine 16Nivolumab 16Irinotecan 15Carboplatin 13Biopsy 13Etoposide 12Vincristine 11Pemetrexed 11Lomustine 11dinutuximab 9Surgical Procedures, Operative 9trametinib 8abemaciclib 8Ipilimumab 8naxitamab 7fluciclovine F-18 7Watchful Waiting 7Topotecan 7Proton Therapy 7Magnetic Resonance Imaging 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Carmustine × CNS × Clear all
NCT04222062 2026-04-28

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

University of Nebraska

Phase 2 Recruiting
100 enrolled
CNS

Brain Neoplasms

NCT05052957 2025-11-21

hSTAR GBM

Case Comprehensive Cancer Center

Phase 2 Recruiting
16 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡